Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Inhibrx Biosciences Q2 EPS $(1.85) Beats $(2.76) Estimate, Sales $1.300M Up From $100.000K YoY

Author: Benzinga Newsdesk | August 13, 2025 03:28pm

Posted In: INBX